Ionis Pharmaceuticals, Inc. (IONS)

NASDAQ: IONS · Real-Time Price · USD

78.66

-3.30 (-4.03%)

At close: Mar 3, 2026, 4:00 PM EST

79.80

+1.14 (1.45%)

After-hours: Mar 3, 2026, 4:35 PM EST

Ionis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	372.26	242.08	399.27	276.47	869.19
Short-Term Investments	2,308	2,061	1,938	1,721	1,264
Cash & Short-Term Investments	2,680	2,303	2,338	1,997	2,133
Cash Growth	16.39%	-1.48%	17.03%	-6.37%	12.32%
Receivables	66.06	92.19	97.78	25.54	61.9
Inventory	10.05	12.51	7.44	22.03	24.81
Other Current Assets	234.08	212.67	199.13	157.72	125.17
Total Current Assets	2,991	2,620	2,642	2,203	2,345
Property, Plant & Equipment	361.6	256.11	242.94	255.84	196.04
Long-Term Investments	52.21	41.02	42.99	40.37	32.32
Other Long-Term Assets	119.4	86.26	62.29	34.97	38.28
Total Assets	3,524	3,004	2,990	2,534	2,612
Accounts Payable	28.08	42.96	26.03	17.92	11.9
Accrued Expenses	222.33	178.05	215.62	189.28	127.37
Current Portion of Long-Term Debt	445.63	0.22	45.07	0.32	0.9
Current Portion of Leases	9.06	9.06	8.09	7.22	2.63
Current Income Taxes Payable	2.71	0.03	2.15	6.25	0.04
Current Unearned Revenue	73.76	78.99	151.13	90.58	97.71
Total Current Liabilities	781.57	309.32	448.09	311.56	240.55
Long-Term Debt	1,899	1,788	1,743	1,183	1,228
Long-Term Leases	262.38	161.81	170.88	178.94	19.43
Long-Term Unearned Revenue	92	156.5	241.18	287.77	351.88
Total Liabilities	3,035	2,415	2,603	1,961	1,840
Common Stock	0.16	0.16	0.14	0.14	0.14
Additional Paid-In Capital	3,145	2,869	2,215	2,060	1,964
Retained Earnings	-2,631	-2,250	-1,796	-1,430	-1,160
Comprehensive Income & Other	-25.28	-30.81	-32.65	-57.48	-32.67
Total Common Equity	489.09	588.35	386.69	572.89	771.74
Shareholders' Equity	489.09	588.35	386.69	572.89	771.74
Total Liabilities & Equity	3,524	3,004	2,990	2,534	2,612
Total Debt	2,616	1,959	1,967	1,369	1,251
Net Cash (Debt)	64.58	344.14	370.23	628.21	882.13
Net Cash Growth	-81.23%	-7.05%	-41.07%	-28.78%	-8.06%
Net Cash Per Share	0.40	2.30	2.59	4.43	6.26
Filing Date Shares Outstanding	165.19	158.96	145.75	142.95	141.69
Total Common Shares Outstanding	163.3	157.91	144.34	142.06	141.21
Working Capital	2,209	2,311	2,194	1,891	2,104
Book Value Per Share	2.99	3.73	2.68	4.03	5.47
Tangible Book Value	489.09	588.35	386.69	572.89	771.74
Tangible Book Value Per Share	2.99	3.73	2.68	4.03	5.47
Land	-	8.57	8.57	8.57	23.06
Buildings	41.8	41.23	41.23	41.16	144.05
Machinery	11.72	9.86	9.84	9.58	10.59
Leasehold Improvements	89.15	54.38	28.28	28.36	20.14

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q